130 abstracts found.

An ultra-high resolution view of clonal evolution

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Jamie Blundell¹

¹University of Cambridge

Developing immune stratification for cancer: targeting the tumour microenvironment

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Gareth Thomas¹

¹University of Southampton

Integration of validated protein biomarkers within Molecular Pathology Diagnostic Service: the challenges

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Phillippe Taniere¹

¹University Hospital Birmingham

A leader with good emotional Intelligence makes a positive difference to supporting a worker after a cancer diagnosis

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Fehmidah Munir¹

¹Loughborough University

What works and what doesn’t in cancer pain: A summary of recent clinical trial evidence

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Mike Bennett¹

¹University of Leeds

Pathophysiology of Cancer Associated Thrombosis

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Simon Noble¹

¹Cardiff University

Engineering T cells for pediatric cancer immunotherapy

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Stephen Gottschalk¹

¹St Jude Children's Research Hospital

The case for no surgery

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

David Sebag-Montefiore¹

¹St James' University Hospital

The case for robotics

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Mark Gudgeon¹

¹Frimley Park Hospital

Cancer evolution across multiple tumour types

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

David Wedge¹

¹University of Oxford

Deep and dense data in cancer imaging

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Julia Schnabel¹

¹King's College London

Defining the mechanisms and biomarkers of PDGFR inhibitor resistance and response

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Paul Huang¹

¹The Institute of Cancer Research

Working after a diagnosis of cancer: Why is it important and how can we support it?

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Angela de Boer¹

¹Academic Medical Center

Phenotypic screening for novel antibody targets in the tumour microenvironment

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Sandrine Legg¹

¹MedImmune Ltd

The Breast Cancer Weight Loss (BWEL) Trial

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Jennifer Ligibel¹

¹Dana-Farber Cancer Institute

Physical activity and common cancers: From prevention to survivorship

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

John Saxton¹

¹Northumbria University

Molecular classification of pediatric brain tumors identifies new brain tumor entities

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Marcel Kool¹

¹German Cancer Research Center DKFZ

Metabolic requirements of prostate cancer pathogenesis and progression

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Arkaitz Carracedo Perez¹

¹CIC bioGUNE

Heterocellular metabolic crosstalk in pancreatic tumors

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Costas Lyssiotis¹

¹University of Michigan

Towards Next-Generation Cancer Cell Culture Models

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Mathew Garnett¹

¹The Wellcome Trust

Helping your patient lose weight – what the busy clinician should do

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Paul Aveyard¹

¹University of Oxford

Obesity, metabolic dysfunction and cancer: Molecular epidemiologic approaches

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Marc Gunter¹

¹International Agency for Research on Cancer

Marketing and promotion of obesity in children

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Jyotsna Vohra¹

¹Cancer Research UK

PET for staging, risk stratification and guiding therapy in lymphoma

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Sally Barrington¹

¹King's College London

PSMA targeting in prostate cancer

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Matthias Eiber¹

¹Technical University Munich - Dept. of Nuclear Medicine

Radiotherapy to the post neoadjuvant chemotherapy breast and axilla

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Anna Kirby¹

¹Royal Marsden Hospital/ Institute of Cancer Research

Pathological consideration in the neoadjuvant setting

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Abeer Shaaban¹

¹NIHR Clinical Research Network: West Midlands

Identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Henry Kuerer¹

¹University of Texas MD Anderson Cancer Center

Fluorescence guided imaging in reconstructive surgery

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Gunther Felmerer¹

¹University Medicine Göttingen

How strong is the evidence on the role of diet, nutrition, physical activity and cancer?

Year: 2017

Session type: Oral

Theme: Invited speaker abstract

Martin Wiseman¹

¹World Cancer Research Fund